Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 25.99% is 14% below its 5-year average of 30.23%, near the low end of its 5-year range (13.79%–61.56%).
As of the fiscal period ended Tuesday, June 30, 2026. 7.20% below its 12-month average of 28.01%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 25.99%.
DEBT TO ASSETS RATIO
25.99%
DEBT TO ASSETS RATIO AVG TTM
28.01%
DEBT TO ASSETS RATIO AVG 3Y
22.06%
DEBT TO ASSETS RATIO AVG 5Y
30.23%
DEBT TO ASSETS RATIO AVG 10Y
57.73%
DEBT TO ASSETS RATIO AVG 15Y
49.39%
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-7.20%
CURRENT VS 3Y AVG
+17.84%
CURRENT VS 5Y AVG
-14.01%
CURRENT VS 10Y AVG
-54.97%
CURRENT VS 15Y AVG
-47.38%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 638 covered companies
CURRENT VS SECTOR MEDIAN
+25893.51%
vs the sector median at left
Cosmos Health Inc.
Market Cap
$18.45M
Debt to Assets Ratio
25.99%
TTM Avg
28.01%
3Y Avg
22.06%
5Y Avg
30.23%
Market Cap
$18.70M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$18.77M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$17.01M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.81M
Debt to Assets Ratio
0.14%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.78M
Debt to Assets Ratio
0.77%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$19.84M
Debt to Assets Ratio
0.08%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cosmos Health Inc. (COSM) | $18.45M | 25.99% | 28.01% | 22.06% | 30.23% |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.70M | 0.00% | N/A | N/A | N/A |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.77M | 0.00% | N/A | N/A | N/A |
| NextCure, Inc. (NXTC)vs › | $18.82M | 0.19% | N/A | N/A | N/A |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.01M | 0.00% | N/A | N/A | N/A |
| Lipocine Inc. (LPCN)vs › | $16.98M | 0.00% | N/A | N/A | N/A |
| Bionano Genomics, Inc. (BNGO)vs › | $16.81M | 0.14% | N/A | N/A | N/A |
| Dyadic International, Inc. (DYAI)vs › | $16.78M | 0.77% | N/A | N/A | N/A |
| Actuate Therapeutics Inc (ACTU)vs › | $19.84M | 0.08% | N/A | N/A | N/A |
| BioCardia, Inc. (BCDA)vs › | $16.08M | 0.06% | N/A | N/A | N/A |
Debt/Assets
26.0%
Debt/Equity
0.77
Current Ratio
1.05
Interest Coverage
-6.3x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 25.99% |
| 2026-03-31 | 27.93% |
| 2025-12-31 | 30.50% |
| 2025-09-30 | 30.32% |
| 2025-06-30 | 25.30% |
| 2025-03-31 | 22.47% |
| 2024-12-31 | 21.76% |
| 2024-09-30 | 17.09% |
| 2024-06-30 | 19.42% |
| 2024-03-31 | 18.29% |
| 2023-12-31 | 18.82% |
| 2023-09-30 | 15.08% |
| 2023-06-30 | 13.79% |
| 2023-03-31 | 14.35% |
| 2022-12-31 | 17.67% |
| 2022-09-30 | 50.69% |
| 2022-06-30 | 47.50% |
| 2022-03-31 | 44.53% |
| 2021-12-31 | 54.87% |
| 2021-09-30 | 56.87% |
| 2021-06-30 | 61.56% |
| 2021-03-31 | 68.66% |
| 2020-12-31 | 76.63% |
| 2020-09-30 | 79.94% |
| 2020-06-30 | 81.36% |
| 2020-03-31 | 91.73% |
| 2019-12-31 | 80.76% |
| 2019-09-30 | 88.06% |
| 2019-06-30 | 81.67% |
| 2019-03-31 | 73.40% |
| 2018-12-31 | 80.10% |
| 2018-09-30 | 69.44% |
| 2018-06-30 | 97.75% |
| 2018-03-31 | 102.22% |
| 2017-12-31 | 95.34% |
| 2017-09-30 | 91.83% |
| 2017-06-30 | 92.08% |
| 2017-03-31 | 80.83% |
| 2016-12-31 | 102.58% |
| 2016-09-30 | 107.53% |
| 2016-06-30 | 90.12% |
| 2016-03-31 | 78.08% |
| 2015-12-31 | 72.10% |
| 2015-09-30 | 9.11% |
| 2015-06-30 | 8.35% |
| 2015-03-31 | 8.30% |
| 2014-12-31 | 6.97% |
| 2014-09-30 | 2.29% |
| 2014-06-30 | 7.84% |
| 2014-03-31 | 16.71% |
| 2013-12-31 | 19.03% |
| 2013-09-30 | 29.93% |
| 2013-07-31 | 0.00% |
| 2013-04-30 | 2034.84% |
| 2013-01-31 | 33937.97% |
| 2012-10-31 | 12715.49% |
| 2012-07-31 | 0.00% |
| 2012-04-30 | 984.26% |
| 2012-01-31 | 28725.58% |
| 2011-10-31 | 140.53% |
| 2011-07-31 | 0.00% |
| 2011-04-30 | 8.14% |
| 2011-01-31 | 1593.57% |
| 2010-10-31 | 30523.08% |
| 2010-07-31 | 3377.02% |
| 2010-04-30 | 156.13% |
| 2010-01-31 | 107.59% |
